Abstract

BackgroundAlzheimer’s disease (AD) is an important, progressive neurodegenerative disease, with a complex genetic architecture. A key goal of biomedical research is to seek out disease risk genes, and to elucidate the function of these risk genes in the development of disease. For this purpose, expanding the AD-associated gene set is necessary. In past research, the prediction methods for AD related genes has been limited in their exploration of the target genome regions. We here present a genome-wide method for AD candidate genes predictions.MethodsWe present a machine learning approach (SVM), based upon integrating gene expression data with human brain-specific gene network data, to discover the full spectrum of AD genes across the whole genome.ResultsWe classified AD candidate genes with an accuracy and the area under the receiver operating characteristic (ROC) curve of 84.56% and 94%. Our approach provides a supplement for the spectrum of AD-associated genes extracted from more than 20,000 genes in a genome wide scale.ConclusionsIn this study, we have elucidated the whole-genome spectrum of AD, using a machine learning approach. Through this method, we expect for the candidate gene catalogue to provide a more comprehensive annotation of AD for researchers.

Highlights

  • Alzheimer’s disease (AD) is an important, progressive neurodegenerative disease, with a complex genetic architecture

  • We used human, tissue-specific networking to discover the full spectrum of AD genes across the whole genome

  • Alzheimer’s disease genes spectrum After initially collecting 335 AD-associated genes [Additional file 2], we classified these genes into four categories, based on the strength of supporting evidence

Read more

Summary

Introduction

Alzheimer’s disease (AD) is an important, progressive neurodegenerative disease, with a complex genetic architecture. A key goal of biomedical research is to seek out disease risk genes, and to elucidate the function of these risk genes in the development of disease For this purpose, expanding the AD-associated gene set is necessary. A key goal of biomedical research is to seek out disease risk genes, and to elucidate the function of these risk genes in the development of disease and the complex networks of gene-gene interactions underlying complex traits [4]. With the rapid development of sequencing technology, large amounts of new sequence data must be

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.